BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35548525)

  • 1. Integration of ESG Information Into Individual Investors' Corporate Investment Decisions: Utilizing the UTAUT Framework.
    Park SR; Oh KS
    Front Psychol; 2022; 13():899480. PubMed ID: 35548525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which institutional investors can improve the level of corporate ESG information disclosure?
    Wang J; Ke Y; Zhang H; Cheng Y
    PLoS One; 2023; 18(11):e0290008. PubMed ID: 37976317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating nutrition and obesity prevention considerations into institutional investment decisions regarding food companies: Australian investment sector perspectives.
    Robinson E; Parker C; Carey R; Foerster A; Blake MR; Sacks G
    Global Health; 2022 Nov; 18(1):93. PubMed ID: 36348484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Extent to Which Obesity and Population Nutrition Are Considered by Institutional Investors Engaged in Responsible Investment in Australia - A Review of Policies and Commitments.
    Robinson E; Parker C; Carey R; Sacks G
    Front Psychol; 2020; 11():577816. PubMed ID: 33424688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does ESG performance affect stock returns? Empirical evidence from listed companies in China.
    Yin XN; Li JP; Su CW
    Heliyon; 2023 May; 9(5):e16320. PubMed ID: 37305472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of companies disclosing ESG reports in multiple languages on the enthusiasm of foreign investors for holding shares.
    Bao R; Wei L
    PLoS One; 2024; 19(3):e0299643. PubMed ID: 38452011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Institutional investors' site visits and investment-cash flow sensitivity: Mitigating financing constraints or inhibiting agent conflicts?
    Liao J; Zhan Y; Yuan Y
    PLoS One; 2024; 19(3):e0300332. PubMed ID: 38547151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nexus between corporate environment, social, and governance performance and cost of capital: evidence from top global tech leaders.
    Nazir M; Akbar M; Akbar A; Poulovo P; Hussain A; Qureshi MA
    Environ Sci Pollut Res Int; 2022 Mar; 29(15):22623-22636. PubMed ID: 34791632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental, social, and governance (ESG) performance and financial outcomes: Analyzing the impact of ESG on financial performance.
    Chen S; Song Y; Gao P
    J Environ Manage; 2023 Nov; 345():118829. PubMed ID: 37688968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do environmental, social, and governance scores improve green innovation? Empirical evidence from Chinese-listed companies.
    Zhang C; Chen D
    PLoS One; 2023; 18(5):e0279220. PubMed ID: 37228130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landscape analysis of environmental, social and governance (ESG) investing metrics for consumer nutrition and health in the food and beverage sector.
    O'Hearn M; Reedy J; Robinson E; Economos C; Wong JB; Sacks G; Mozaffarian D
    BMJ Nutr Prev Health; 2023 Dec; 6(2):139-152. PubMed ID: 38264364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESG practices mitigating geopolitical risks: Implications for sustainable environmental management.
    Alnafrah I
    J Environ Manage; 2024 May; 358():120923. PubMed ID: 38652985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESG performance, auditing quality, and investment efficiency: Empirical evidence from China.
    Wang W; Yu Y; Li X
    Front Psychol; 2022; 13():948674. PubMed ID: 36312099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental-, social-, and governance-related factors for business investment and sustainability: a scientometric review of global trends.
    Ahmad H; Yaqub M; Lee SH
    Environ Dev Sustain; 2023 Jan; ():1-23. PubMed ID: 36714213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Firm's Unethical Behavior in Investment Decisions Among Young Investors in China.
    Tang X; Yu K; Yu W
    Psychol Res Behav Manag; 2022; 15():3427-3443. PubMed ID: 36466762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Effectiveness of Sustainability Measurement: Which ESG Metrics Will Survive COVID-19?
    Atkins J; Doni F; Gasperini A; Artuso S; La Torre I; Sorrentino L
    J Bus Ethics; 2022 Aug; ():1-18. PubMed ID: 35967487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifting focus from end-of-pipe treatment to source control: ESG ratings' impact on corporate green innovation.
    Wang Z; Chu E
    J Environ Manage; 2024 Mar; 354():120409. PubMed ID: 38401500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investment Recommender System Model Based on the Potential Investors' Key Decision Factors.
    Asemi A; Asemi A; Ko A
    Big Data; 2023 May; ():. PubMed ID: 37155679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breaking the ESG rating divergence: An open geospatial framework for environmental scores.
    Rossi C; Byrne JG; Christiaen C
    J Environ Manage; 2024 Jan; 349():119477. PubMed ID: 37944316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial sanctions and environmental, social, and governance (ESG) performance: A comparative study of ownership responses in the Chinese context.
    Ahmed R; Abweny M; Benjasak C; Nguyen DTK
    J Environ Manage; 2024 Feb; 351():119718. PubMed ID: 38128214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.